School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
Swallowing Rehabilitation Research Laboratory, KITE Research Institute, University Health Network, Toronto, Ontario, Canada.
Am J Speech Lang Pathol. 2023 Sep 11;32(5):2331-2350. doi: 10.1044/2023_AJSLP-22-00380. Epub 2023 Jul 12.
Practice pattern studies suggest that liquid modification is currently a primary strategy used by speech-language pathologists to manage dysphagia; however, the breadth of negative consequences associated with their use is not well understood. The purpose of this review was to summarize the evidence on adverse events and effects of thickened liquid (TL) use in adults.
Six databases were searched in February 2022: EMBASE, MEDLINE (PubMed), Speechbite, AMED, AgeLine, and CINAHL. Articles were included if they compared adults receiving different TL viscosities and discussed at least one adverse event or effect of consuming TLs. Articles were excluded if they were review articles, rehabilitation studies, rheological analyses, not in English, or not peer reviewed. Screening and data extraction were completed by two independent reviewers. Risk of bias was assessed using Cochrane tools.
Thirty-three studies ( = 4,990 participants across all studies) were eligible for inclusion (2,405 unique records screened). Reported adverse events included dehydration ( = 5), pneumonia ( = 4), death ( = 2), urinary tract infection ( = 1), and hospitalization ( = 1); adverse effects included reduced quality of life ( = 18), aspiration ( = 12), reduced intake ( = 8), increased residue ( = 4), and reduced medication bioavailability ( = 2). Results were mapped on to codes and domains of the International Classification of Functioning, Disability and Health.
A range of adverse outcomes associated with TL use were identified. Adverse outcomes should be monitored and reported in dysphagia research. Given current research evidence, it is vital for clinicians to weigh the risks and benefits of TL use to mitigate potential adverse outcomes.
实践模式研究表明,液体改良目前是言语语言病理学家管理吞咽困难的主要策略;然而,人们对其使用相关的负面后果知之甚少。本综述的目的是总结关于成年人使用增稠液(TL)的不良事件和影响的证据。
于 2022 年 2 月在六个数据库中进行了检索:EMBASE、MEDLINE(PubMed)、Speechbite、AMED、AgeLine 和 CINAHL。如果文章比较了接受不同 TL 粘度的成年人,并讨论了至少一种 TL 摄入的不良事件或影响,则将其纳入。如果文章是综述文章、康复研究、流变学分析、非英文或未经同行评审,则将其排除在外。两名独立审查员完成了筛选和数据提取。使用 Cochrane 工具评估偏倚风险。
有 33 项研究(所有研究中共有 4990 名参与者)符合纳入标准(筛查了 2405 份独特记录)。报告的不良事件包括脱水(5 例)、肺炎(4 例)、死亡(2 例)、尿路感染(1 例)和住院(1 例);不良影响包括生活质量降低(18 例)、误吸(12 例)、摄入量减少(8 例)、残留物增加(4 例)和药物生物利用度降低(2 例)。结果被映射到国际功能、残疾和健康分类的代码和领域。
确定了与 TL 使用相关的一系列不良结果。在吞咽困难研究中应监测和报告不良结果。鉴于当前的研究证据,临床医生权衡 TL 使用的风险和益处以减轻潜在的不良后果至关重要。